In this study, a conjoint analysis of TET2 was performed using data from TCGA and GEO to assess the following aspects: transcriptional level, clinical outcomes, DNA methylation, genetic mutations, cancer immune infiltration, and related signaling pathways. The gene discussed is TET2; the disease is cancer.